Clinical Trial Update: Extended-Release Tacrolimus Following Liver Transplantation [Phase 4]

View source ↗

Summary

This document reports a Phase 4 clinical trial evaluating extended-release tacrolimus in liver transplant recipients, currently recruiting to assess safety and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Liver Transplantation
• Metabolic Syndrome
• Renal Insufficiency

Drugs mentioned

• Tacrolimus extended-release (Tacrolimus)

Snippet

Sponsor: University of Alberta | Conditions: Liver Transplant; Complications, Renal Insufficiency | Phase 4 | Status: RECRUITING